|
1.
|
Delattre O, Zucman J, Plougastel B, et al:
Gene fusion with an ETS DNA-binding domain caused by chromosome
translocation in human tumours. Nature. 359:162–165. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Arvand A and Denny CT: Biology of EWS/ETS
fusions in Ewing’s family tumors. Oncogene. 20:5747–5754. 2001.
|
|
3.
|
Delattre O, Zucman J, Melot T, et al: The
Ewing family of tumors - a subgroup of small-round-cell tumors
defined by specific chimeric transcripts. N Engl J Med.
331:294–299. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Sorensen PH, Lessnick SL, Lopez-Terrada D,
Liu XF, Triche TJ and Denny CT: A second Ewing’s sarcoma
translocation, t(21;22), fuses the EWS gene to another ETS-family
transcription factor, ERG. Nat Genet. 6:146–151. 1994.
|
|
5.
|
Zucman J, Melot T, Desmaze C, et al:
Combinatorial generation of variable fusion proteins in the Ewing
family of tumours. EMBO J. 12:4481–4487. 1993.PubMed/NCBI
|
|
6.
|
Peter M, Couturier J, Pacquement H, et al:
A new member of the ETS family fused to EWS in Ewing tumors.
Oncogene. 14:1159–1164. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kaneko Y, Yoshida K, Handa M, et al:
Fusion of an ETS-family gene, E1AF, to EWS by t(17;22)(q12;q12)
chromosome trans-location in an undifferentiated sarcoma of
infancy. Genes Chromosomes Cancer. 15:115–121. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Urano F, Umezawa A, Hong W, Kikuchi H and
Hata J: A novel chimera gene between EWS and E1A-F, encoding the
adenovirus E1A enhancer- binding protein, in extraosseous Ewing’s
sarcoma. Biochem Biophys Res Commun. 219:608–612. 1996.PubMed/NCBI
|
|
9.
|
Jeon IS, Davis JN, Braun BS, et al: A
variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to
the ETS gene ETV1. Oncogene. 10:1229–1234. 1995.
|
|
10.
|
Smith MA, Seibel NL, Altekruse SF, et al:
Outcomes for children and adolescents with cancer: challenges for
the twenty-first century. J Clin Oncol. 28:2625–2634. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Bacci G, Ferrari S, Longhi A, et al:
Therapy and survival after recurrence of Ewing’s tumours: the
Rizzoli experience in 195 patients treated with ajuvant and
neoajuvant chemotherapy from 1979 to 1997. Ann Oncol. 14:1654–1659.
2003.
|
|
12.
|
Paulussen M, Bielack S, Jürgens H and
Casali PG; ESMO Guidelines Working Group: Ewing’s sarcoma of the
bone: ESMO clinical recommendations for diagnosis,treatment and
follow-up. Ann Oncol. 20:140–142. 2009.
|
|
13.
|
Rosito P, Mancini AF, Rondelli R, et al:
Italian Cooperative Study for the treatment of children and young
adults with localized Ewing sarcoma of bone: a preliminary report
of 6 years of experience. Cancer. 86:421–428. 1999.PubMed/NCBI
|
|
14.
|
McTiernan AM, Cassoni AM, Driver D, et al:
Improving Outcomes After Relapse in Ewing’s Sarcoma: Analysis of
114 Patients From a Single Institution. Sarcoma.
2006:835482006.PubMed/NCBI
|
|
15.
|
Grier HE, Krailo MD, Tarbell NJ, et al:
Addition of ifosfamide and etoposide to standard chemotherapy for
Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl
J Med. 348:694–701. 2003.
|
|
16.
|
Indelicato DJ, Keole SR, Shahlaee AH, et
al: Long-term clinical and functional outcomes after treatment for
localized Ewing’s tumor of the lower extremity. Int J Radiat Oncol
Biol Phys. 70:501–509. 2008.PubMed/NCBI
|
|
17.
|
Rodríguez-Galindo C, Liu T, Krasin MJ, Wu
J, et al: Analysis of prognostic factors in ewing sarcoma family of
tumors: review of St. Jude Children’s Research Hospital studies.
Cancer. 110:375–384. 2007.
|
|
18.
|
Bacci G, Forni C, Longhi A, et al:
Long-term outcome for patients with non-metastatic Ewing’s sarcoma
treated with adjuvant and neoadjuvant chemotherapies. 402 patients
treated at Rizzoli between 1972 and 1992. Eur J Cancer. 40:73–83.
2004.
|
|
19.
|
Donati D, Yin J, Di Bella C, et al: Local
and distant control in non-metastatic pelvic Ewing’s sarcoma
patients. J Surg Oncol. 96:19–25. 2007.PubMed/NCBI
|
|
20.
|
Gasparini M, Lombardi F, Ballerini E, et
al: Long-term outcome of patients with monostotic Ewing’s sarcoma
treated with combined modality. Med Pediatr Oncol. 23:406–412.
1994.PubMed/NCBI
|
|
21.
|
McLean TW, Hertel C, Young ML, et al: Late
events in pediatric patients with Ewing sarcoma/primitive
neuroectodermal tumor of bone: the Dana-Farber Cancer
Institute/Children’s Hospital experience. J Pediatr Hematol Oncol.
2:486–493. 1999.PubMed/NCBI
|
|
22.
|
Lin PP, Jaffe N, Herzog CE, et al:
Chemotherapy response is an important predictor of local recurrence
in Ewing sarcoma. Cancer. 109:603–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
